```html

Nicotinia (Nicotine Poisoning) – A Complete Medical Guide

Overview

Nicotine poisoning, medically termed nicotinia, occurs when the body is exposed to a toxic level of nicotine. While nicotine is the addictive alkaloid found in tobacco plants, it is also present in nicotine replacement therapies (NRTs), e‑cigarette liquids, insecticides, and some garden products.

Most cases involve accidental ingestion—especially in children—or intentional overdose in adults. The U.S. Centers for Disease Control and Prevention (CDC) estimate that 1,500–2,000 cases of acute nicotine poisoning are reported each year in the United States, with the majority (≈80 %) occurring in children under six years of age. However, a rise in e‑cigarette use has led to a 10‑15 % increase in reported cases between 2018‑2022.

Nicotine poisoning can affect anyone who comes into contact with high‑dose nicotine, but certain groups are at higher risk:

• Children – accidental swallowing of liquid nicotine, nicotine gum, or patches.
• Adolescents and young adults – misuse of e‑liquids or “vaping” devices, especially with high‑concentration solutions (≥50 mg/mL).
• Adults with psychiatric illness – intentional overdose as a means of self‑harm.
• Farmers and pest‑control workers – occupational exposure to nicotine‑based insecticides.

Symptoms

Symptoms of nicotinia follow a biphasic pattern—initial stimulation from nicotine’s agonist effect on nicotinic acetylcholine receptors, followed by a depressive phase as receptors become desensitized.

Early (Stimulatory) Phase (0‑30 minutes)

• Salivation and drooling – excessive oral secretions.
• Sweating (diaphoresis) – often profuse.
• Nausea, vomiting, and abdominal cramps – gastrointestinal irritation.
• Headache – throbbing or pressure‑type.
• Racing heart rate (tachycardia) – may reach >130 bpm.
• Hypertension – systolic pressure often >150 mmHg.
• Facial flushing and pallor – mixed vasomotor response.
• Muscle fasciculations – brief, fine twitches, especially around the mouth and neck.
• Anxiety or agitation – restlessness, irritability.

Late (Depressive) Phase (30‑120 minutes)

• Bradycardia – heart rate falls below 60 bpm.
• Hypotension – systolic pressure <90 mmHg.
• Respiratory depression – shallow breathing, possible apnea.
• Confusion, seizures, or loss of consciousness.
• Muscle weakness or paralysis – may progress to respiratory muscles.
• Marked sweating or, paradoxically, dry skin (due to autonomic collapse).
• Cardiac arrhythmias – ventricular tachycardia, fibrillation (rare but life‑threatening).

Symptoms usually appear within 5–30 minutes of exposure, peak within an hour, and resolve over 2–6 hours as nicotine is metabolized, provided the dose is not lethal.

Causes and Risk Factors

Nicotine poisoning can result from several sources:

• Oral ingestion of nicotine replacement products (gum, lozenges, patches), especially when used improperly or chewed.
• E‑cigarette liquids (e‑juice) – many contain 3–50 mg/mL nicotine; accidental ingestion of a few milliliters can be fatal for small children.
• Nicotine pesticides – historically used in agriculture; still found in some organophosphate‑based products.
• Dermal absorption from nicotine patches or handling concentrated nicotine solutions without gloves.
• Inhalation of high‑concentration vapor (e.g., “nicotine clouds” from sub‑ohm vaping devices).

Key Risk Factors

• Improper storage – liquids kept in candy‑like containers.
• High‑concentration nicotine products – >20 mg/mL for e‑juice, >4 mg for patches.
• Lack of awareness – parents unaware of the toxicity of nicotine pods.
• Pre‑existing cardiac disease – may exacerbate nicotine‑induced arrhythmias.
• Poor renal or hepatic function – reduces nicotine clearance, increasing systemic levels.

Diagnosis

Diagnosis is primarily clinical, based on a clear history of exposure and characteristic signs. Prompt recognition is critical because laboratory confirmation may take time.

History and Physical Examination

• Ask about recent use of tobacco, NRTs, e‑cigarettes, or insecticides.
• Enquire about the amount, formulation (liquid, patch, gum), and timing of exposure.
• Perform a focused exam for autonomic signs (pupillary changes, sweating) and neurological status.

Laboratory Tests

• Serum nicotine level – measured by gas chromatography–mass spectrometry; therapeutic levels are 0.03‑0.07 mg/L, toxic >0.5 mg/L.
• Serum cotinine – nicotine metabolite, useful for confirming exposure when nicotine level is low.
• Basic metabolic panel – to assess electrolytes, especially potassium (hypokalemia may occur with vomiting).
• Arterial blood gas (ABG) – to detect respiratory depression and metabolic acidosis.
• ECG – for arrhythmias, QT prolongation.

Imaging

Imaging is rarely needed unless aspiration of vomitus is suspected (chest X‑ray) or there is concern for co‑ingested substances.

Treatment Options

Management of nicotinia focuses on supportive care, decontamination (if within the appropriate time window), and symptomatic treatment.

Immediate First‑Aid Steps

1. Call emergency services (911 in the U.S.) if the patient is unconscious, seizing, or showing signs of severe toxicity.
2. Remove the source – discard any remaining nicotine product to prevent further exposure.
3. Assess airway, breathing, circulation (ABCs) – secure the airway if the patient is vomiting or unable to protect it.

Decontamination

• Gastric lavage – considered only if the patient presents within 1 hour of ingestion and the airway is protected.
• Activated charcoal – 1 g/kg PO can bind nicotine; most effective within 30–60 minutes of ingestion.
• Dermal decontamination – wash skin thoroughly with soap and water if patches or liquids have contacted the skin.

Supportive Care

• Intravenous fluids – isotonic saline to maintain blood pressure and renal perfusion.
• Oxygen therapy – titrated to maintain SpO₂ > 94 %.
• Monitoring – continuous cardiac telemetry for arrhythmias; repeat ECGs every 30 minutes initially.
• Anticonvulsants – benzodiazepines (e.g., lorazepam 0.1 mg/kg IV) for seizures.
• Bronchodilators – albuterol inhaler for bronchospasm.

Pharmacologic Antidotes

There is no specific nicotine antidote. However, the following agents may be employed:

• Atropine – for severe bradycardia or muscarinic symptoms; 0.5 mg IV every 3–5 minutes as needed.
• Vasopressors – norepinephrine may be required for refractory hypotension.
• Diazepam or phenobarbital – alternative seizure control if benzodiazepines are contraindicated.

Observation Period

Patients with mild exposure (e.g., a single nicotine gum chew) can be observed for 4–6 hours. Those with moderate‑to‑severe poisoning require 12–24 hours of monitoring, as nicotine’s half‑life is 1–2 hours but severe cardiovascular effects may persist.

Discharge Planning

Before discharge, clinicians should ensure:

• Stable vital signs for at least 2 hours.
• Absence of recurrent vomiting or neurological decline.
• Clear instructions for follow‑up with primary care or a poison control center.

Living with Nicotinia (Nicotine Poisoning)

Even after an acute episode, patients may have ongoing concerns, especially if they use nicotine replacement therapies or vape regularly.

Self‑Monitoring

• Keep a symptom diary for any lingering fatigue, dizziness, or palpitations.
• Measure blood pressure at home if you experienced hypertension during the event.
• Watch for signs of nicotine dependence—cravings, irritability, or use escalation.

Lifestyle Adjustments

• Store nicotine products safely—out of reach of children, in locked cabinets.
• Switch to lower‑dose NRT if you require nicotine for quitting smoking; discuss options with a healthcare provider.
• Consider behavioral counseling or FDA‑approved cessation programs (e.g., Nicotine Anonymous, quitlines).
• Stay hydrated and maintain a balanced diet to support hepatic metabolism of nicotine.

Follow‑Up Care

Schedule a follow‑up visit within 1 week after discharge to review:

• Any persistent cardiovascular symptoms.
• Psychological impact—especially after intentional overdose.
• Need for referral to addiction medicine or mental‑health services.

Prevention

Because nicotine is widely available, prevention relies on education, safe storage, and regulation.

• Child‑proof packaging – Legislation in the U.S., EU, and Canada now requires nicotine liquids to be sold in child‑resistant containers.
• Labeling – Prominent warnings about toxicity, especially for concentrations ≥20 mg/mL.
• Education for caregivers – Public‑health campaigns highlighting that nicotine is as poisonous as many household cleaners.
• Proper disposal – Use designated drop‑off sites for used e‑cigarette cartridges and patches.
• Workplace safety – Training for agricultural personnel handling nicotine pesticides, including use of gloves and eye protection.

Complications

If untreated or inadequately managed, nicotine poisoning can lead to serious sequelae:

• Cardiac arrhythmias – ventricular tachycardia or fibrillation, which may cause sudden cardiac death.
• Respiratory failure – due to central depression or neuromuscular weakness, often requiring mechanical ventilation.
• Seizure‑related injury – trauma from falls or status epilepticus.
• Acute kidney injury – secondary to prolonged hypotension or rhabdomyolysis from muscle fasciculations.
• Long‑term neurocognitive effects – rare, but severe hypoxia can cause memory deficits.

When to Seek Emergency Care

Even if symptoms appear mild, children should be evaluated by a healthcare professional because their smaller body size makes them more susceptible to toxic effects.

---

References

1. Mayo Clinic. Nicotine Overdose. Updated 2023.
2. CDC. Poisoning Data & Statistics. Accessed May 2026.
3. National Institutes of Health. Acute Nicotine Toxicity: Clinical Features and Management. 2020.
4. World Health Organization. Tobacco: Health Effects. 2022.
5. Cleveland Clinic. Nicotine Poisoning. Reviewed 2024.
6. U.S. Poison Control Center Network. Nicotine Poisoning Clinical Guidelines. 2023.

```